VIVO Crosses Above Average Analyst Target
July 21, 2016 at 09:50 AM EDT
In recent trading, shares of Meridian Bioscience Inc. (VIVO) have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.13/share..